NASDAQ: VVOS
Vivos Therapeutics Inc Stock Ownership - Who owns Vivos Therapeutics?

Insider buying vs selling

Have Vivos Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael C. Skaff10% Owner2026-03-31308,848$1.34
$413.86kBuy
Michael C. Skaff10% Owner2026-03-311,044,777$1.34
$1.40MBuy

1 of 1

VVOS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VVOS insiders and whales buy or sell their stock.

VVOS Shareholders

What type of owners hold Vivos Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Gurdev Dave Singh16.00%3,219,705$898.30kInsider
Michael C. Skaff13.40%2,696,123$752.22kInsider
Ronald Kirk Huntsman9.06%1,822,061$508.36kInsider
Vco Investors 3 LLC6.73%1,353,625$377.66kInsider
Gregg C. Johnson0.02%3,997$1.12kInsider
Geode Capital Management LLC0.00%85$23.72Institution
Geodec0.00%85$23.72Institution
Bradford K. Amman0.00%80$22.32Insider
Iht Wealth Management LLC0.00%77$21.48Institution
Ihtwea0.00%77$21.48Institution

1 of 3

VVOS vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VVOS0.00%45.21%Net Buying
ICCM0.00%79.70%
AMIX0.00%100.00%
ITOC0.00%45.17%
BMRA0.00%100.00%

Vivos Therapeutics Stock Ownership FAQ

Who owns Vivos Therapeutics?

Vivos Therapeutics (NASDAQ: VVOS) is owned by 0.00% institutional shareholders, 45.21% Vivos Therapeutics insiders, and 54.79% retail investors. Gurdev Dave Singh is the largest individual Vivos Therapeutics shareholder, owning 3.22M shares representing 16.00% of the company. Gurdev Dave Singh's Vivos Therapeutics shares are currently valued at $956.25k.

If you're new to stock investing, here's how to buy Vivos Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.